Seattle, WA -- (SBWIRE) -- 11/07/2019 -- Global Constipation Treatment Market Overview

Constipation is a digestive disorder that refers to infrequent bowel movement or hard-to-pass stool. Commonly found in women and geriatric population, constipation leads to lumpy and hard stools along with discomfort in abdomen, straining to have bowel, and feeling of blockage in rectum that prevents bowel movements. Various factors are responsible for constipation such as low-fiber diet, dehydration, little to no physical activity, and mental conditions such as depression or eating disorder. Changing the lifestyle is primary step to treat constipation along with change in diet, in order to increase the speed at which stool moves through intestine. Increasing high-fiber diet and adopting physical activities such as exercise can increase the intestinal muscle activities. However, in severe cases physicians recommend medications or surgery.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/95

Segmentation of Global Constipation Treatment Market

Constipation treatment market is segmented on the basis of type, treatment, method of administration, and end use. By type, the global constipation treatment market has been categorized into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC). On the basis of treatment, the global constipation treatment market has been categorized into pharmacological treatment and non-pharmacological treatment, which comprises bowel training for constipation relief, fluid intake, dietary fiber intake and regular exercise. Further, pharmacological treatment is categorized into bulk-forming agents, stool softeners and emollients, osmotic agents, stimulants such as Bisacodyl, castor oil, senna and Cascara Sagrada, and chloride channel activators. On the basis of method of administration, the global constipation treatment market is categorized into oral and parenteral (subcutaneous injection). On the basis of distribution, the global constipation treatment market is segmented into hospital pharmacies, drug stores, and independent pharmacies.

Market Dynamics- Drivers

High prevalence rate in North America drive growth of the Constipation Treatment Market

High prevalence of constipation in North America due to increasing adoption of unhealthy lifestyle characterized by growing consumption of fast food is leading to increasing obesity and other related health issues. This inadvertently leads to high incidence rate of constipation, which in turn, is expected to drive growth of the global constipation treatment market during the forecast period.

According to the American Society of Interventional Pain Physicians, the U.S. accounts for around 80% of the global opioids consumption. According to an article published in the American Gastroenterological Association in May 2015, chronic constipation affects one in six people in the U.S. and is the third-leading symptom prompting outpatient clinic visits in the country. It is especially prevalent in overweight women. Europe is expected to witness significant growth in the global constipation treatment during the forecast period. This is owing to high acuity information system, high disposable income level, and rampant adoption of unhealthy lifestyle in the region. Furthermore, Asia Pacific is expected witness lucrative growth in the market, owing to increasing westernization characterized by rising adoption of non-nutritious fast food in the region.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/95

Market Dynamics- Restraints

However, product recall in some regions is expected to hider the market growth. For instance, in August 2019, the UAE Ministry of Health and Prevention issued a circular on noting the withdrawal of Laxocodyl suppositories batch used for the treatment of constipation in adults, produced by JulpharGulf Pharmaceutical Industries, as a result of incorrect labeling.

Global players engaged in the constipation treatment market 

Key players operating in the global constipation treatment market are AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Valeant Pharmaceuticals International, Inc., C.B. Fleet Company Inc., Daewoong Co. Ltd., Sucampo Pharmaceuticals Inc., Cosmo Pharmaceuticals, Synergy Pharmaceuticals Inc. Boehringer Ingelheim GmbH, and Ironwood Pharmaceuticals. 

Key Developments in the global constipation treatment market 

1. Major companies in the market are involved in various growth strategies such as gaining product approvals from regulatory bodies, in order to expand their product portfolio. For instance, in December 2018, the U.S. FDA approved Prucalopride, a selective serotonin-4 (5-HT4) receptor agonist that is administered as a once-daily, oral treatment for chronic idiopathic constipation, developed by Shire Plc., s U.S-registered specialty Biopharmaceutical Company.
2. Key players in the market are involved in varies business strategies such as research and development, in order enhance their market presence. For instance, in May 2019, DuPont de Nemours, Inc. published results of a randomized, controlled trial that assessed the impact of lactitol and psyllium on bowel function in constipated Indian volunteers.   

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/constipation-treatment-market-95

About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.